Connect with us

Technology

DHL Group acquires CRYOPDP from Cryoport to strengthen “DHL Health Logistics”

Published

on

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and cell & gene therapies. This acquisition enhances DHL’s capabilities in specialty pharma logistics and supports Group’s 2030 strategy to become a leader in life science and healthcare logistics.DHL and Cryoport form strategic partnership to strengthen their respective supply chain services offerings for the global life sciences and healthcare sector.

BONN, Germany and NASHVILLE, Tenn., March 31, 2025 /PRNewswire/ — DHL Group (“DHL”), the world’s leading logistics provider, and Cryoport, Inc. (NASDAQ: CYRX) (“Cryoport”), a global provider of supply chain solutions for the life sciences sector, are pleased to announce that DHL has acquired 100% of CRYOPDP, a leading specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context, the companies also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector.

DHL Group already has an established Life Sciences and Healthcare business, contributing over EUR 5 billion in global revenue in 2024. Building on this foundation, the acquisition of CRYOPDP marks a significant step in DHL’s commitment to enhancing its capabilities in specialized pharma logistics and expanding the breadth of its offering in the rapidly growing life science and healthcare sector. CRYOPDP specializes in providing white-glove courier services essential to the sectors it serves. With operations in 15 countries, CRYOPDP handles over 600,000 shipments per year, servicing customers and patients in over 135 countries worldwide.

Going forward, DHL Supply Chain will further build the potential of its Pharma Specialized Network solution by leveraging the specialty courier expertise of newly acquired CRYOPDP and the global air capabilities of DHL Express and DHL Global Forwarding.

The strategic partnership with Cryoport will bring together DHL’s global health logistics capabilities with Cryoport’s industry-leading expertise in providing specialized solutions in a fast growing life science and healthcare market segment. It also deepens DHL’s relationship with all the Cryoport business units with respect to specialized pharma.

Oscar de Bok, CEO of DHL Supply Chain, stated, “The acquisition of CRYOPDP is a pivotal move for our supply chain business as we aim to expand our Pharma Specialized Network to meet the evolving needs of clinical trials, biopharma and cell & gene therapies, in addition to further increasing our footprint in the conventional pharma and life science healthcare segment. The acquisition of CRYOPDP and the extended partnership with Cryoport Inc. will enable us to deliver integrated end-to-end solutions, enhancing our service capabilities .”

Jerrell Shelton, CEO of Cryoport, commented “We are indeed pleased to build on our trusted relationship with the DHL Group. Working together we will bring an enhanced set of supply chain solutions to meet companies’ and patients’ critical supply chain needs. This strategic partnership taps into the strong expertise of DHL’s Supply Chain and CRYOPDP, presenting a substantial opportunity for Cryoport to further expand its reach to global growth markets such as Asia Pacific (APAC) and Europe, Middle East and Africa (EMEA).”

The acquisition aligns with DHL Group’s Strategy 2030, which emphasizes the importance of temperature-controlled networks, first and last mile specialty courier coverage and integrated solutions. CRYOPDP’s capabilities will be instrumental in achieving these objectives and help position DHL as a leader in providing comprehensive solutions for the pharma industry. This strategic move is also expected to yield cost savings and improve overall service levels, especially leveraging DHL Express and DHL Global Forwarding air capabilities, ultimately enhancing DHL’s footprint in the high-value advanced pharma sector.

For Cryoport, the partnership with DHL will enable it to better execute its business in EMEA and APAC with a stronger focus on its core business in these regions, creating even greater opportunities to offer highly targeted, top-tier services in answering market demand for its services and products.  

The deal and the outlined partnership are subject to regulatory approvals.

On the internet: group.dhl.com/press
Follow us at: twitter.com/DHLglobal

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 395,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.

DHL is part of DHL Group. The Group generated revenues of more than 81.8 billion euros in 2023. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. DHL Group aims to achieve net-zero emissions logistics by 2050.

About Cryoport, Inc.

Cryoport, Inc. (Nasdaq: CYRX), is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers to carry out their respective business with products and services that are designed to derisk services and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are “Enabling the Future of Medicine™” worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.

Our corporate headquarters, located in Nashville, Tennessee, is complemented by over 50 global locations in 17 countries, with key sites in the United States, United Kingdom, France, the Netherlands, Belgium, Portugal, Germany, Japan, Australia, India, and China.

For more information, visit www.cryoportinc.com or follow via LinkedIn at https://www.linkedin.com/company/cryoportinc or @cryoport on X, formerly known as Twitter at www.twitter.com/cryoport for live updates.

Forward-Looking Statements

Statements in this press release which are not purely historical, including statements regarding Cryoport’s intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, those related to Cryoport’s expectations about future benefits of the sale of CRYOPDP and the strategic collaboration with DHL, including the potential impact on future revenue and revenue streams.  It is important to note that Cryoport’s actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, risks and uncertainties associated with the effect of changing economic and geopolitical conditions, supply chain constraints, inflationary pressures, the effects of foreign currency fluctuations, trends in the products markets, variations in Cryoport’s cash flow, market acceptance risks, and technical development risks. Cryoport’s business could be affected by other factors discussed in Cryoport’s SEC reports, including in the “Risk Factors” section of its most recently filed periodic reports on Form 10-K and Form 10-Q, as well as in its subsequent filings with the SEC. The forward-looking statements contained in this press release speak only as of the date hereof and Cryoport cautions investors not to place undue reliance on these forward-looking statements. Except as required by law, Cryoport disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dhl-group-acquires-cryopdp-from-cryoport-to-strengthen-dhl-health-logistics-302415637.html

SOURCE Cryoport, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TriNet to Report First Quarter 2025 Financial Results on April 25

Published

on

By

DUBLIN, Calif., April 4, 2025 /PRNewswire/ — TriNet (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs), today announced it will release financial results for the first quarter ended March 31, 2025 before U.S. market hours on Friday, April 25, 2025.

TriNet will host a conference call at 5:30 a.m. PT (8:30 a.m. ET) on April 25, 2025, to discuss the financial results. A live webcast of the conference call can be accessed on the Investor Relations section of TriNet’s website at investor.trinet.com. Participants can pre-register for the webcast by going to: https://events.q4inc.com/attendee/796608745.

Participants can also pre-register for the upcoming conference call. Those who pre-register will receive a unique PIN, enabling instant access to the call. To pre-register, visit: https://dpregister.com/sreg/10198705/fee38a6e3d.

Participants who do not pre-register for the call can still join by dialing +1 877 328 5510 and asking to attend the TriNet first quarter earnings conference call.

A replay of the webcast will be available on the TriNet site for approximately one year.

About TriNet 
TriNet (NYSE: TNET) provides comprehensive HR solutions, technology, expertise, and access to world-class benefits that enable small and medium-sized businesses (SMBs) to attract and develop top-tier talent. Rooted in more than 30 years of supporting entrepreneurs and adapting to the ever-changing modern workplace, TriNet empowers SMBs to focus on what matters most—growing their business and enabling their people. For more information, visit TriNet.com or follow us on Facebook, LinkedIn and Instagram

Investors:                                                        

Media:

Alex Bauer                                                               

Renee Brotherton/Josh Gross

TriNet                                                             

TriNet

Alex.Bauer@TriNet.com                                         

Renee.Brotherton@TriNet.com

Josh.Gross@TriNet.com

TriNet and the TriNet logo are registered trademarks of TriNet. All other trademarks, service marks, registered trademarks, or registered service marks are the property of their respective owners.

View original content to download multimedia:https://www.prnewswire.com/news-releases/trinet-to-report-first-quarter-2025-financial-results-on-april-25-302420841.html

SOURCE TriNet Group, Inc.

Continue Reading

Technology

DuPont Wins Four Edison Awards

Published

on

By

WILMINGTON, Del., April 4, 2025 /PRNewswire/ — DuPont (NYSE:DD) today announced that four of its innovative material technologies were recognized with the prestigious 2025 Edison Awards™. Selected from hundreds of nominees, DuPont received two Gold awards, a Silver and a Bronze.

“We’re honored that four of our innovative technologies have been recognized for delivering exceptional performance and creating lasting value for our customers,” said Alexa Dembek, DuPont Chief Technology and Sustainability Officer. “This achievement reflects the ingenuity and commitment to innovation of our teams and demonstrates the meaningful impact of our close customer collaboration to bring cutting-edge technologies to market.” 

The four DuPont innovations awarded this year include:

Gold – Kevlar® EXO™ aramid fiber won a Gold in the Critical Safety Material Advancements category. Kevlar® EXO™ aramid fiber is a breakthrough aramid fiber innovation that delivers best-in-class ballistic protection as well as the highest level of flexibility compared to competitive solutions, providing increased comfort and mobility to users. It is also inherently flame-retardant, further setting it apart from non-aramid ballistic solutions. Kevlar® EXO™ is a copolymer which allows for greater control in development of the fiber structure resulting in 30 percent higher strength than standard aramid body armor fibers. As a result, overall ballistic system performance is improved while reducing other layers of the system. With unmatched pliability, Kevlar® EXO™ contours to curves and body lines, providing a more body-inclusive solution while still offering maximum protection. The result is the highest ballistics performance among all aramid fibers without compromising on weight, enabling the lightest weight soft armor solutions available on the market today.

Gold – Tyvek® Trifecta™ A2 breather membrane won a Gold in the High-Performance Engineering Materials category. Tyvek® Trifecta™ A2 breather membrane technology is a unique combination of its innovative lamination process and product design, combining a thin, robust monolithic polymer film with a non-combustible glass fiber substrate. This results in a lighter product while delivering long-lasting performance for increased energy efficiency requirements and ever-tightening fire regulations in the UK and EU. The choice of a monolithic (continuous, without pores) layer enables a more durable, better water-resistant, and more airtight patent-pending solution. These product benefits also save installation time and costs. Tyvek® Trifecta™ has been developed for residential, commercial, and mixed use. The benchmark set by this innovation is expected to drive development across the construction industry, resulting in further safety and energy conservation benefits for society.

Silver – AmberLite™ P2X110 ion exchange resin won a Silver in the Energy Storage and Management category. AmberLite™ P2X110 is designed to enable longevity and efficiency during the production of hydrogen from water. High-purity water is crucial for the efficiency and longevity of the Proton Exchange Membrane (PEM) electrolyzers that produce hydrogen from water. The AmberLite™ P2X110 ion exchange resin offers durable and reliable water quality that helps remove impurities and prevent contaminant build-up in electrolyzer loops. Designed to endure the thermal and chemical challenges presented in an electrolyzer, the specially tailored formula of AmberLite™ P2X110 ion exchange resins helps provide longer and more robust performance than industry-generic resins.

Bronze – DuPont™ Ikonic™ 9000 semiconductor polishing pad won a Bronze in the Semiconductor Innovations for AI & HPC category. DuPont™ Ikonic™ 9000 semiconductor polishing pads are a new expansion to the Ikonic™ polishing pad family for advanced node semiconductor fabrication, designed to meet polishing needs for advanced chips for use in AI, high-performance computing, and Internet of Things applications. In addition to addressing the increased chemical mechanical planarization (CMP) performance requirements at advanced nodes, pads in the Ikonic™ 9000 series enable significant process improvements for chip fabricators due to longer pad lifespan and groove design for slurry efficiency. Ikonic™ 9000 pads are designed for efficiency and productivity in semiconductor fabrication with a high removal rate, offering higher wafer throughput while optimizing production time and energy consumption. Semiconductor fabs can gain meaningful sustainability benefits through the increased productivity of their CMP processes and equipment.

Established in 1987, The Edison Awards™ recognize excellence in new product and service development, marketing, design, and innovation. Developed and maintained in the legacy of Thomas Edison, The Edison Awards™ “symbolize the persistence and excellence personified by Thomas Edison and his Menlo Park team, while also strengthening the human drive for innovation, creativity, and ingenuity.” 

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.comInvestors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-wins-four-edison-awards-302420569.html

SOURCE DuPont

Continue Reading

Technology

Kirby McInerney LLP Announces a Proposed Settlement in the DraftKings NFT Settlement

Published

on

By

CHICAGO, April 4, 2025 /PRNewswire/ —

Have you purchased, sold, or held DraftKings NFTs?

If you purchased, sold, held, or otherwise transacted in DraftKings NFTs at any point from August 11, 2021, through and inclusive of the date of entry of the judgment, you should read this Notice of Class Action Settlement as it may impact your legal rights.

A court authorized this notice. This is not a solicitation.

You must file a Claim Form by July 21, 2025, to receive cash benefits from this Settlement. To file a Claim, please visit the website www.DraftKingsNFTSettlement.com.

A Settlement has been reached with DraftKings Inc. and certain of its officers (“DraftKings”) in Dufoe v. DraftKings, No. 1:23-cv-10524 (D. Mass.), a class action lawsuit (the “Action”) alleging that NFTs purchased, sold, held, or otherwise transacted on the DraftKings Marketplace constitute securities that were not registered in accordance with federal and state law. The Action also alleges that the DraftKings Marketplace is a securities exchange and DraftKings acts as a securities broker when transacting in NFTs, neither of which were registered as required by federal and state law. DraftKings denies all allegations of wrongdoing.

Your options are: (1) stay in the Settlement Class and submit a claim; (2) ask to be excluded from the Settlement Class (opt out); or (3) object to the Settlement.

The Court has appointed Class Counsel to represent you and will decide whether to approve the Settlement at a Final Approval Hearing currently scheduled for July 30, 2025. That date is subject to change without further notice. A current date of the Final Approval Hearing can be found on the Settlement website.

Class Counsel may ask the Court for an award of attorneys’ fees up to one-third of the $10 million Settlement Amount, and costs not to exceed $100,000, as well as a Service Award not to exceed $50,000 for Lead Plaintiff. The Court will determine the amounts to be paid, which will come from the Settlement Amount.

To learn more about your options or to contact Class Counsel, you may visit the Settlement website at www.DraftKingsNFTSettlement.com or call (877) 883-9186. The deadline to file a claim is July 21, 2025, and the deadline to opt out or object is July 9, 2025.

PLEASE DO NOT CONTACT THE COURT OR THE COURT CLERK’S OFFICE REGARDING THIS NOTICE, THIS SETTLEMENT, OR THE CLAIMS PROCESS.

View original content:https://www.prnewswire.com/news-releases/kirby-mcinerney-llp-announces-a-proposed-settlement-in-the-draftkings-nft-settlement-302417561.html

SOURCE Kirby McInerney LLP

Continue Reading

Trending